Taipei Medical University Institutional Repository:Item 987654321/57950
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45069/58245 (77%)
造訪人次 : 2372038      線上人數 : 175
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/57950


    題名: 樟芝併用aspirin在大鼠暫時性腦血管梗塞之作用探討
    Study of Antrodia camphorata combined with aspirin in transient MCAO
    作者: 余孟哲
    Yu, Meng-Che
    貢獻者: 醫學科學研究所
    馮琮涵
    關鍵詞: 暫時性腦血管梗塞;大鼠;樟芝;阿斯匹靈
    MCAO;Rat;Antrodia camphorat;aspirin
    日期: 2014-06-30
    上傳時間: 2019-09-03 11:43:27 (UTC+8)
    摘要: 腦中風是國內十大死因之第三位,且目前尚無藥物能夠有效治療腦中風,因此腦中風患者的照護時常帶給社會龐大負擔。台灣原生種真菌—樟芝,因富含大量三萜類而被作為保健食品,廣泛應用於肝病或是癌症的輔助治療上;近來亦有研究指出,樟芝在腦中風及心血管疾病的預防及治療上可能具有其功效,但其機轉及可能的副作用尚不清楚。Aspirin 為目前臨床上最常使用來治療或預防腦中風的藥物,但是許多研究皆指出 aspirin具有出血性副作用的風險;因此尋找有效治療腦中風的藥物,研究其機轉及降低治療藥物的出血性副作用,為目前腦中風研究上的重要課題。另外,台灣有許多病患會同時併用西藥及保健食品來治療和預防中風,因此我們除了分別探討樟芝及 aspirin在缺血性腦中風的療效外,亦進一步探討此兩者併用對於治療缺血性腦中風的交互作用 ,以及觀察其出血性副作用。
    本實驗利用線栓引發中大腦動脈梗塞動物模式,探討缺血/再灌流 24小時後,分別管餵樟芝 (0.25 及 0.75 g/kg)、aspirin (5 mg/kg)或併用兩者 2個月,藥物對缺血性腦中風的影響。研究 結果發現樟芝不論單獨或併用 aspirin皆顯著降低缺血性傷害,並且加速改善其神經行為功能。另外,樟芝 (0.75 g/kg)單獨或併用 aspirin (5 mg/kg)能有效降低缺血性中風所引起的 iNOS、HO-1、Bax 及 actived caspase-3表現。利用電子自旋共振儀,我們也發現樟芝 (40 mg/ml)具有清除氫氧自由基 (OH˙)的能力。除此之外,不論單獨餵食樟芝或併用 aspirin皆無發生顱內出血、蜘蛛膜下腔出血和胃出血等副作用,凝血酶原時間亦無顯著影響。
    本篇論文證明不論單獨給予樟芝 (0.25 及 0.75 g/kg)、aspirin (5 mg/kg)或併用兩者皆能透過抑制細胞凋亡、降低氧化壓力、降低缺血性腦傷害及改善神經功能,而具有神經保護作用,並且各組都未表現出血性的副作用。因此本論文提供了樟芝在治療缺血性腦中風臨床應用上的科學化依據 ,相信不論是單獨使用樟芝或者併用其他抗血小板藥物來治療缺血性中風,在未來皆為值得進一步研究探討的課題。
    Stroke is the third leading cause of mortality in Taiwan. So far, there are no better medicine to treat stroke. Therefore, this disease always results a heavy social burden in taking care of patient.Antrodia camphorata, a native species of fungi in Taiwan,is considered as a dietary supplement due to the enrichment of triterpenoid. It has been widely used in liver disease or even cancertreatment. Recently, some studies also indicated that Antrodia camphorata maybe beneficial on the prevention and treatment of stroke and cardiovascular diseases,but the mechanism and possible side effect are not well known yet.Aspirin is the most commonly used drug in clinic for the treatment or prevention of stroke, but many studies indicated aspirin has a higher risk of hemorrhage. Thus, to drug in the remedy of stroke with better effectiveness and less adverse effect is an important issue of stroke research.On the other hand, there are many patients in Taiwan concurrently takewestern medicine and health food to treat and prevent of stroke.Therefore, in the present study, wetreated aspirin combined with Antrodia camphoratato investigate their protective efficacy after ischemic stroke. In addition, we alsoestimate hemorrhagic side effects.
    In this study, our results showed that treatment of Antrodia camphorata (0.25 or 0.75 g/kg) in the absence or presence of aspirin (5 mg/kg) by oral gavages daily after transient MCAO for two months markedly reduced infarct size and improved neurologic functions.We further observed several proteins, including iNOS, HO-1, Bax, and caspase-3, which are associated with brain injury. Our data revealed that Antrodia camphorate markedly decrease the expression of these proteins. Antrodia camphorata In addition, treatment of Antrodia camphorata combined with aspirin or not didn’t have side effects of hemorrhage such as intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), gastric bleeding (GB), and prothrombin time (PT).
    In conclusion, this study demonstrates that given alone Antrodia camphorata (0.25 and 0.75 g / kg), aspirin (5 mg / kg) or with both has a potent neuroprotective activity. This activity is mediated, at least in part, through inhibition of apoptosis, oxidative stress, resulting in a reduction of infarct volume and improvement in neurobehavior in rats with focal cerebral ischemia without hemorrhaging side effects. Therefore, Antrodia camphorata may represent high therapeutic potential and safe for treatment of ischemic stroke.
    描述: 碩士
    指導教授-馮琮涵
    共同指導教授-許準榕
    委員-張釗監
    委員-楊志豪
    委員-林冠宏
    資料類型: thesis
    顯示於類別:[醫學科學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML60檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋